These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15232137

  • 21. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE, Fox LE, Brower JC, Gaskin A, Kurzman ID, Kubilis PS.
    Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Principles of treatment for mast cell tumors.
    Govier SM.
    Clin Tech Small Anim Pract; 2003 May; 18(2):103-6. PubMed ID: 12831070
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
    Schlieben P, Meyer A, Weise C, Bondzio A, Gruber AD, Klopfleisch R.
    J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
    [Abstract] [Full Text] [Related]

  • 31. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L.
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [Abstract] [Full Text] [Related]

  • 32. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
    Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA.
    Clin Cancer Res; 2003 Nov 15; 9(15):5729-34. PubMed ID: 14654558
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
    Baginski H, Davis G, Bastian RP.
    J Am Anim Hosp Assoc; 2014 Nov 15; 50(2):89-95. PubMed ID: 24446400
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
    Cahalane AK, Payne S, Barber LG, Duda LE, Henry CJ, Mauldin GE, Frimberger AE, Cotter SM, Moore AS.
    J Am Vet Med Assoc; 2004 Aug 01; 225(3):401-8. PubMed ID: 15328716
    [Abstract] [Full Text] [Related]

  • 36. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
    Hämäläinen S, Kareinen L, Sukura A, Kareinen I.
    Vet Pathol; 2022 Mar 01; 59(2):236-243. PubMed ID: 34894899
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.